<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">68929</article-id><article-id pub-id-type="doi">10.7554/eLife.68929</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-233042"><name><surname>Ngan</surname><given-names>Nguyen Thi Thuy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238847"><name><surname>Thanh Hoang Le</surname><given-names>Nhat</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233047"><name><surname>Vi Vi</surname><given-names>Nguyen Ngo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233048"><name><surname>Van</surname><given-names>Ninh Thi Thanh</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233049"><name><surname>Mai</surname><given-names>Nguyen Thi Hoang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233050"><name><surname>Anh</surname><given-names>Duong Van</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233051"><name><surname>Trieu</surname><given-names>Phan Hai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233052"><name><surname>Lan</surname><given-names>Nguyen Phu Huong</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-53570"><name><surname>Phu</surname><given-names>Nguyen Hoan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101443"><name><surname>Chau</surname><given-names>Nguyen VV</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233053"><name><surname>Lalloo</surname><given-names>David G</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233054"><name><surname>Hope</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233055"><name><surname>Beardsley</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235652"><name><surname>White</surname><given-names>Nicholas J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1897-1978</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101439"><name><surname>Geskus</surname><given-names>Ronald</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13542"><name><surname>Thwaites</surname><given-names>Guy E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2858-2087</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-136449"><name><surname>Krysan</surname><given-names>Damian</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233057"><name><surname>Tai</surname><given-names>Luong Thi Hue</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-101437"><name><surname>Kestelyn</surname><given-names>Evelyne</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5728-0918</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233058"><name><surname>Binh</surname><given-names>Tran Quang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233059"><name><surname>Hung</surname><given-names>Le Quoc</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-233060"><name><surname>Tung</surname><given-names>Nguyen Le Nhu</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-101433"><name><surname>Day</surname><given-names>Jeremy N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7843-6280</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Tropical Medicine</institution>, <institution>Cho Ray Hospital</institution>, <addr-line><named-content content-type="city">Ho Chi Minh City</named-content></addr-line>, <country>Viet Nam</country></aff><aff id="aff2"><institution>Oxford University Clinical Research Unit</institution>, </aff><aff id="aff3"><institution content-type="dept">Department of Microbiology</institution>, <institution>Hospital for Tropical Diseases</institution>, <addr-line><named-content content-type="city">Ho Chi Minh CIty</named-content></addr-line>, <country>Viet Nam</country></aff><aff id="aff4"><institution content-type="dept">Director</institution>, <institution>Liverpool School of Tropical Medicine</institution>, <addr-line><named-content content-type="city">Liverpool</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Centre of Excellence in Infectious Disease Research</institution>, <institution>Liverpool University</institution>, <addr-line><named-content content-type="city">Liverpool</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><institution content-type="dept">Marie Bashir Institute</institution>, <institution>University of Sydney</institution>, <addr-line><named-content content-type="city">Sydney</named-content></addr-line>, <country>Australia</country></aff><aff id="aff7"><institution>Mahidol Oxford Tropical Medicine Research Unit</institution>, <addr-line><named-content content-type="city">Bangkok</named-content></addr-line>, <country>Thailand</country></aff><aff id="aff8"><institution>University of Iowa</institution>, <addr-line><named-content content-type="city">Iowa City</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Infectious Diseases</institution>, <institution>Hospital for Tropical Diseases</institution>, <addr-line><named-content content-type="city">Ho Chi Minh City</named-content></addr-line>, <country>Viet Nam</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-56354"><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name><role>Reviewing editor</role><aff><institution>Radboudumc Center for Infectious Diseases</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jday@oucru.org</email> (JD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>09</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e68929</elocation-id><history><date date-type="received"><day>30</day><month>03</month><year>2021</year></date><date date-type="accepted"><day>21</day><month>09</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Ngan et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ngan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-68929-v1.pdf"/><abstract><p><bold>Background:</bold> Cryptococcal meningitis has high mortality. Flucytosine is a key treatment but is expensive and rarely available. The anti-cancer agent tamoxifen has synergistic anti-cryptococcal activity with amphotericin in vitro. It is off-patent, cheap, and widely available. We performed a trial to determine its therapeutic potential.</p><p><bold>Methods:</bold>Open label randomized controlled trial. Participants received standard care - amphotericin combined with fluconazole for the first two weeks - or standard care plus tamoxifen 300mg/day. The primary end point was Early Fungicidal Activity (EFA) - the rate of yeast clearance from cerebrospinal fluid (CSF). Trial registration https://clinicaltrials.gov/ct2/show/NCT03112031 .</p><p><bold>Results:</bold> 50 patients were enrolled, (median age 34 years, 35 male). Tamoxifen had no effect on EFA (- 0.48log10 colony-forming units/mL/CSF control arm versus -0.49 tamoxifen arm, difference - 0.005log10CFU/ml/day, 95%CI: -0.16, 0.15, P=0.95). Tamoxifen caused QTc prolongation.</p><p><bold>Conclusion:</bold> High dose tamoxifen does not increase the clearance rate of Cryptococcus from CSF. Novel, affordable therapies are needed.</p><p><bold>Funding:</bold>The trial was funded through the Wellcome Trust Asia Programme Vietnam Core Grant 106680 and a Wellcome Trust Intermediate Fellowship to JND grant number WT097147MA.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>Wellcome Trust Asia Programme Vietnam Core Grant 106680</award-id><principal-award-recipient><name><surname>Thwaites</surname><given-names>Guy E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>WT097147MA</award-id><principal-award-recipient><name><surname>Day</surname><given-names>Jeremy N</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study protocol was approved by the Ethical Review Committees of the Hospital for Tropical Diseases, Cho Ray Hospital, and the Vietnamese Ministry of Health, and by the Oxford University Tropical Research Ethics Committee. A trial steering committee with 2 independent members oversaw the running of the trial, and an independent data and safety monitoring committee oversaw trial safety. The first safety analysis was performed after the first 20 patients had reached the primary endpoint. The funding bodies and drug manufacturers played no role in the study design, implementation, analysis, or manuscript preparation. All the authors made the decision to submit the manuscript for publication and vouch for the accuracy and completeness of the data and analyses presented. The trial was registered at https://clinicaltrials.gov/ct2/show/NCT03112031.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The clinical trial has been conducted in Vietnam under the Ministry of Health and local Ethical Committee approvals. Requests to share the clinical data underlying the trial have to be acknowledged by the local Ethical Committee (and therefore we cannot hand over the data repository or management to an external party). The original de-identified clinical data underlying the study are available by emailing the OUCRU Data Access Committee at DAC@oucru.org or ekestelyn@oucru.org (Head of the Clinical Trials Unit and Data Access Committee Chair). The review procedures (the data sharing policy and the data request form) are available on the OUCRU website at http://www.oucru.org/data-sharing/The code for the study analysis is freely available at https://doi.org/10.5287/bodleian:XmeOzdR8z</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Ngan et al</collab></person-group><year iso-8601-date="2021">2021</year><source>28CN:   AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS</source><ext-link ext-link-type="uri" xlink:href="www.oucru.org">www.oucru.org</ext-link><comment>28CN</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Ngan et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Statistical Analysis Code: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS</source><ext-link ext-link-type="uri" xlink:href="https://ora.ox.ac.uk/objects/uuid:e8d738f8-e2d2-49b3-8774-4ad192c3c265">https://ora.ox.ac.uk/objects/uuid:e8d738f8-e2d2-49b3-8774-4ad192c3c265</ext-link><comment>doi.org/10.5287/bodleian:XmeOzdR8z</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-68929-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>